Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1‐3 tyrosine kinase inhibitor anticancer therapy

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Anticancer Therapy ◽

Fibroblast Growth ◽

Interdigitation Zone

Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors

Investigational New Drugs ◽

10.1007/s10637-017-0514-4 ◽

2017 ◽

Vol 36 (3) ◽

pp. 424-434 ◽

Cited By ~ 32

Author(s):

Tomohiro Nishina ◽

Shunji Takahashi ◽

Ryota Iwasawa ◽

Hidehisa Noguchi ◽

Masayuki Aoki ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Solid Tumors ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3-Specific Tyrosine Kinase Inhibitor in t(4;14) Myeloma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-1612 ◽

2009 ◽

Vol 15 (2) ◽

pp. 520-531 ◽

Cited By ~ 23

Author(s):

G. Bisping ◽

D. Wenning ◽

M. Kropff ◽

D. Gustavus ◽

C. Muller-Tidow ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor

Xenobiotica ◽

10.1080/00498254.2020.1821123 ◽

2020 ◽

Vol 51 (2) ◽

pp. 177-193

Author(s):

Ellen Scheers ◽

Carine Borgmans ◽

Chi Keung ◽

Hilde Bohets ◽

Inneke Wynant ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor

Ophthalmology ◽

10.1016/j.ophtha.2020.08.026 ◽

2020 ◽

Author(s):

M. Teresa Magone ◽

Iris R. Hartley ◽

Edmond Fitzgibbon ◽

Rachel Bishop ◽

Mike Arango ◽

...

Keyword(s):

Growth Factor ◽

Adverse Effects ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Re: Magone et al.: Ocular adverse effects of infigratinib, a new fibroblast growth factor receptor tyrosine kinase inhibitor (Ophthalmology. 2021;128:624–626)

Ophthalmology ◽

10.1016/j.ophtha.2021.05.012 ◽

2021 ◽

Author(s):

Jasmine H. Francis ◽

Julia Canestraro ◽

David H. Abramson

Keyword(s):

Growth Factor ◽

Adverse Effects ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Abstract 3858: Gains in FGF19 are predictive of response to the fibroblast growth factor receptor (FGFR) small molecule tyrosine kinase inhibitor BGJ 398in vitro

10.1158/1538-7445.am2012-3858 ◽

2012 ◽

Cited By ~ 5

Author(s):

Richard S. Finn ◽

Alex Aleshin ◽

Danyun Zhao ◽

Lee Anderson ◽

Charles Ginther ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Small Molecule ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Abstract 3244: Treatment of endometrial cancer cells with a new small tyrosine kinase inhibitor targeting mutated fibroblast growth factor receptor-2

10.1158/1538-7445.am2017-3244 ◽

2017 ◽

Cited By ~ 3

Author(s):

Sebastien Taurin ◽

Chieh-Hsiang Yang ◽

Maria Reyes ◽

Sungpil Cho ◽

Elke A. Jarboe ◽

...

Keyword(s):

Endometrial Cancer ◽

Growth Factor ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

1-tert-Butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a Selective Tyrosine Kinase Inhibitor of Fibroblast Growth Factor Receptor-3 (FGFR3), Inhibits Cell Proliferation of Bladder Cancer Carrying the FGFR3 Gene Mutation along with Up-Regulation of p27/Kip1 and G1/G0 Arrest

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.109.162768 ◽

2009 ◽

Vol 332 (3) ◽

pp. 795-802 ◽

Cited By ~ 46

Author(s):

Makito Miyake ◽

Masazumi Ishii ◽

Naoki Koyama ◽

Kiyotaka Kawashima ◽

Tetsuro Kodama ◽

...

Keyword(s):

Cell Proliferation ◽

Bladder Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Fgfr3 Gene ◽

P27 Kip1

119 ARQ 087: A potent ATP-independent fibroblast growth factor receptor (FGFR) kinase inhibitor showing in vivo anti-tumor activity in FGFR2-driven tumors

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)71824-3 ◽

2010 ◽

Vol 8 (7) ◽

pp. 44-45

Author(s):

C.R. Chen ◽

S. Ali ◽

E. Nakuci ◽

D. McSweeney ◽

J.O. Brown ◽

...

Keyword(s):

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Anti Tumor Activity

Ongoing phase 2 study of erdafitinib (JNJ-42756493), a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients (pts) with metastatic or unresectable urothelial carcinoma (M/UR UC) and FGFR gene alterations

Annals of Oncology ◽

10.1093/annonc/mdw373.72 ◽

2016 ◽

Vol 27 ◽

pp. vi293 ◽

Cited By ~ 2

Author(s):

A.O. Siefker-Radtke ◽

B. Mellado ◽

K. Decaestecker ◽

J.M. Burke ◽

A. O'Hagan ◽

...

Keyword(s):

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Phase 2 ◽

Phase 2 Study ◽

Ongoing Phase ◽

Gene Alterations